Polymer Drug Conjugates Market
1 Study Coverage
1.1 Polymer Drug Conjugates Product Introduction
1.2 Market by Type
1.2.1 Global Polymer Drug Conjugates Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Polymer-Dox Conjugates
1.2.3 Polymer-Paclitaxel Conjugates
1.2.4 Polymer-Camptothecin Conjugates
1.2.5 Polymer-Platinate Conjugates
1.3 Market by Application
1.3.1 Global Polymer Drug Conjugates Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer Treatment
1.3.3 Leukmia
1.3.4 Hepatitis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Polymer Drug Conjugates Sales Estimates and Forecasts 2017-2028
2.2 Global Polymer Drug Conjugates Revenue Estimates and Forecasts 2017-2028
2.3 Global Polymer Drug Conjugates Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Polymer Drug Conjugates Sales by Region
2.4.1 Global Polymer Drug Conjugates Sales by Region (2017-2022)
2.4.2 Global Sales Polymer Drug Conjugates by Region (2023-2028)
2.5 Global Polymer Drug Conjugates Revenue by Region
2.5.1 Global Polymer Drug Conjugates Revenue by Region (2017-2022)
2.5.2 Global Polymer Drug Conjugates Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Polymer Drug Conjugates Sales by Manufacturers
3.1.1 Global Top Polymer Drug Conjugates Manufacturers by Sales (2017-2022)
3.1.2 Global Polymer Drug Conjugates Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Polymer Drug Conjugates in 2021
3.2 Global Polymer Drug Conjugates Revenue by Manufacturers
3.2.1 Global Polymer Drug Conjugates Revenue by Manufacturers (2017-2022)
3.2.2 Global Polymer Drug Conjugates Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Polymer Drug Conjugates Revenue in 2021
3.3 Global Polymer Drug Conjugates Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Polymer Drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Polymer Drug Conjugates Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Polymer Drug Conjugates Sales by Type
4.1.1 Global Polymer Drug Conjugates Historical Sales by Type (2017-2022)
4.1.2 Global Polymer Drug Conjugates Forecasted Sales by Type (2023-2028)
4.1.3 Global Polymer Drug Conjugates Sales Market Share by Type (2017-2028)
4.2 Global Polymer Drug Conjugates Revenue by Type
4.2.1 Global Polymer Drug Conjugates Historical Revenue by Type (2017-2022)
4.2.2 Global Polymer Drug Conjugates Forecasted Revenue by Type (2023-2028)
4.2.3 Global Polymer Drug Conjugates Revenue Market Share by Type (2017-2028)
4.3 Global Polymer Drug Conjugates Price by Type
4.3.1 Global Polymer Drug Conjugates Price by Type (2017-2022)
4.3.2 Global Polymer Drug Conjugates Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Polymer Drug Conjugates Sales by Application
5.1.1 Global Polymer Drug Conjugates Historical Sales by Application (2017-2022)
5.1.2 Global Polymer Drug Conjugates Forecasted Sales by Application (2023-2028)
5.1.3 Global Polymer Drug Conjugates Sales Market Share by Application (2017-2028)
5.2 Global Polymer Drug Conjugates Revenue by Application
5.2.1 Global Polymer Drug Conjugates Historical Revenue by Application (2017-2022)
5.2.2 Global Polymer Drug Conjugates Forecasted Revenue by Application (2023-2028)
5.2.3 Global Polymer Drug Conjugates Revenue Market Share by Application (2017-2028)
5.3 Global Polymer Drug Conjugates Price by Application
5.3.1 Global Polymer Drug Conjugates Price by Application (2017-2022)
5.3.2 Global Polymer Drug Conjugates Price Forecast by Application (2023-2028)
6 North America
6.1 North America Polymer Drug Conjugates Market Size by Type
6.1.1 North America Polymer Drug Conjugates Sales by Type (2017-2028)
6.1.2 North America Polymer Drug Conjugates Revenue by Type (2017-2028)
6.2 North America Polymer Drug Conjugates Market Size by Application
6.2.1 North America Polymer Drug Conjugates Sales by Application (2017-2028)
6.2.2 North America Polymer Drug Conjugates Revenue by Application (2017-2028)
6.3 North America Polymer Drug Conjugates Market Size by Country
6.3.1 North America Polymer Drug Conjugates Sales by Country (2017-2028)
6.3.2 North America Polymer Drug Conjugates Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Polymer Drug Conjugates Market Size by Type
7.1.1 Europe Polymer Drug Conjugates Sales by Type (2017-2028)
7.1.2 Europe Polymer Drug Conjugates Revenue by Type (2017-2028)
7.2 Europe Polymer Drug Conjugates Market Size by Application
7.2.1 Europe Polymer Drug Conjugates Sales by Application (2017-2028)
7.2.2 Europe Polymer Drug Conjugates Revenue by Application (2017-2028)
7.3 Europe Polymer Drug Conjugates Market Size by Country
7.3.1 Europe Polymer Drug Conjugates Sales by Country (2017-2028)
7.3.2 Europe Polymer Drug Conjugates Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Polymer Drug Conjugates Market Size by Type
8.1.1 Asia Pacific Polymer Drug Conjugates Sales by Type (2017-2028)
8.1.2 Asia Pacific Polymer Drug Conjugates Revenue by Type (2017-2028)
8.2 Asia Pacific Polymer Drug Conjugates Market Size by Application
8.2.1 Asia Pacific Polymer Drug Conjugates Sales by Application (2017-2028)
8.2.2 Asia Pacific Polymer Drug Conjugates Revenue by Application (2017-2028)
8.3 Asia Pacific Polymer Drug Conjugates Market Size by Region
8.3.1 Asia Pacific Polymer Drug Conjugates Sales by Region (2017-2028)
8.3.2 Asia Pacific Polymer Drug Conjugates Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Polymer Drug Conjugates Market Size by Type
9.1.1 Latin America Polymer Drug Conjugates Sales by Type (2017-2028)
9.1.2 Latin America Polymer Drug Conjugates Revenue by Type (2017-2028)
9.2 Latin America Polymer Drug Conjugates Market Size by Application
9.2.1 Latin America Polymer Drug Conjugates Sales by Application (2017-2028)
9.2.2 Latin America Polymer Drug Conjugates Revenue by Application (2017-2028)
9.3 Latin America Polymer Drug Conjugates Market Size by Country
9.3.1 Latin America Polymer Drug Conjugates Sales by Country (2017-2028)
9.3.2 Latin America Polymer Drug Conjugates Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Polymer Drug Conjugates Market Size by Type
10.1.1 Middle East and Africa Polymer Drug Conjugates Sales by Type (2017-2028)
10.1.2 Middle East and Africa Polymer Drug Conjugates Revenue by Type (2017-2028)
10.2 Middle East and Africa Polymer Drug Conjugates Market Size by Application
10.2.1 Middle East and Africa Polymer Drug Conjugates Sales by Application (2017-2028)
10.2.2 Middle East and Africa Polymer Drug Conjugates Revenue by Application (2017-2028)
10.3 Middle East and Africa Polymer Drug Conjugates Market Size by Country
10.3.1 Middle East and Africa Polymer Drug Conjugates Sales by Country (2017-2028)
10.3.2 Middle East and Africa Polymer Drug Conjugates Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 3S Bio
11.1.1 3S Bio Corporation Information
11.1.2 3S Bio Overview
11.1.3 3S Bio Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 3S Bio Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 3S Bio Recent Developments
11.2 Abeona Therapeutics
11.2.1 Abeona Therapeutics Corporation Information
11.2.2 Abeona Therapeutics Overview
11.2.3 Abeona Therapeutics Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abeona Therapeutics Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abeona Therapeutics Recent Developments
11.3 Abramson Cancer Center
11.3.1 Abramson Cancer Center Corporation Information
11.3.2 Abramson Cancer Center Overview
11.3.3 Abramson Cancer Center Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abramson Cancer Center Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abramson Cancer Center Recent Developments
11.4 Access Pharmaceuticals
11.4.1 Access Pharmaceuticals Corporation Information
11.4.2 Access Pharmaceuticals Overview
11.4.3 Access Pharmaceuticals Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Access Pharmaceuticals Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Access Pharmaceuticals Recent Developments
11.5 Adama
11.5.1 Adama Corporation Information
11.5.2 Adama Overview
11.5.3 Adama Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Adama Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Adama Recent Developments
11.6 Eyetech
11.6.1 Eyetech Corporation Information
11.6.2 Eyetech Overview
11.6.3 Eyetech Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Eyetech Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eyetech Recent Developments
11.7 Ferring
11.7.1 Ferring Corporation Information
11.7.2 Ferring Overview
11.7.3 Ferring Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ferring Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ferring Recent Developments
11.8 Flamel Technologies
11.8.1 Flamel Technologies Corporation Information
11.8.2 Flamel Technologies Overview
11.8.3 Flamel Technologies Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Flamel Technologies Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Flamel Technologies Recent Developments
11.9 Genentech
11.9.1 Genentech Corporation Information
11.9.2 Genentech Overview
11.9.3 Genentech Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Genentech Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Genentech Recent Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Corporation Information
11.10.2 GlaxoSmithKline Overview
11.10.3 GlaxoSmithKline Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 GlaxoSmithKline Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GlaxoSmithKline Recent Developments
11.11 Gowan
11.11.1 Gowan Corporation Information
11.11.2 Gowan Overview
11.11.3 Gowan Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Gowan Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Gowan Recent Developments
11.12 Gynecologic Oncology Group Foundation
11.12.1 Gynecologic Oncology Group Foundation Corporation Information
11.12.2 Gynecologic Oncology Group Foundation Overview
11.12.3 Gynecologic Oncology Group Foundation Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Gynecologic Oncology Group Foundation Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Gynecologic Oncology Group Foundation Recent Developments
11.13 JenKem Technology
11.13.1 JenKem Technology Corporation Information
11.13.2 JenKem Technology Overview
11.13.3 JenKem Technology Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 JenKem Technology Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 JenKem Technology Recent Developments
11.14 Landec
11.14.1 Landec Corporation Information
11.14.2 Landec Overview
11.14.3 Landec Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Landec Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Landec Recent Developments
11.15 Lipotek
11.15.1 Lipotek Corporation Information
11.15.2 Lipotek Overview
11.15.3 Lipotek Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Lipotek Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Lipotek Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Polymer Drug Conjugates Industry Chain Analysis
12.2 Polymer Drug Conjugates Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polymer Drug Conjugates Production Mode & Process
12.4 Polymer Drug Conjugates Sales and Marketing
12.4.1 Polymer Drug Conjugates Sales Channels
12.4.2 Polymer Drug Conjugates Distributors
12.5 Polymer Drug Conjugates Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Polymer Drug Conjugates Industry Trends
13.2 Polymer Drug Conjugates Market Drivers
13.3 Polymer Drug Conjugates Market Challenges
13.4 Polymer Drug Conjugates Market Restraints
14 Key Findings in The Global Polymer Drug Conjugates Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Polymer Drug Conjugates Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Polymer-Dox Conjugates
Table 3. Major Manufacturers of Polymer-Paclitaxel Conjugates
Table 4. Major Manufacturers of Polymer-Camptothecin Conjugates
Table 5. Major Manufacturers of Polymer-Platinate Conjugates
Table 6. Global Polymer Drug Conjugates Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Polymer Drug Conjugates Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Polymer Drug Conjugates Sales by Region (2017-2022) & (K Pcs)
Table 9. Global Polymer Drug Conjugates Sales Market Share by Region (2017-2022)
Table 10. Global Polymer Drug Conjugates Sales by Region (2023-2028) & (K Pcs)
Table 11. Global Polymer Drug Conjugates Sales Market Share by Region (2023-2028)
Table 12. Global Polymer Drug Conjugates Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Polymer Drug Conjugates Revenue Market Share by Region (2017-2022)
Table 14. Global Polymer Drug Conjugates Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Polymer Drug Conjugates Revenue Market Share by Region (2023-2028)
Table 16. Global Polymer Drug Conjugates Sales by Manufacturers (2017-2022) & (K Pcs)
Table 17. Global Polymer Drug Conjugates Sales Share by Manufacturers (2017-2022)
Table 18. Global Polymer Drug Conjugates Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Polymer Drug Conjugates Revenue Share by Manufacturers (2017-2022)
Table 20. Polymer Drug Conjugates Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 21. Global Polymer Drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Polymer Drug Conjugates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymer Drug Conjugates as of 2021)
Table 23. Polymer Drug Conjugates Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Polymer Drug Conjugates Product Offered
Table 25. Date of Manufacturers Enter into Polymer Drug Conjugates Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Polymer Drug Conjugates Sales by Type (2017-2022) & (K Pcs)
Table 28. Global Polymer Drug Conjugates Sales by Type (2023-2028) & (K Pcs)
Table 29. Global Polymer Drug Conjugates Sales Share by Type (2017-2022)
Table 30. Global Polymer Drug Conjugates Sales Share by Type (2023-2028)
Table 31. Global Polymer Drug Conjugates Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Polymer Drug Conjugates Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Polymer Drug Conjugates Revenue Share by Type (2017-2022)
Table 34. Global Polymer Drug Conjugates Revenue Share by Type (2023-2028)
Table 35. Polymer Drug Conjugates Price by Type (2017-2022) & (USD/Pcs)
Table 36. Global Polymer Drug Conjugates Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 37. Global Polymer Drug Conjugates Sales by Application (2017-2022) & (K Pcs)
Table 38. Global Polymer Drug Conjugates Sales by Application (2023-2028) & (K Pcs)
Table 39. Global Polymer Drug Conjugates Sales Share by Application (2017-2022)
Table 40. Global Polymer Drug Conjugates Sales Share by Application (2023-2028)
Table 41. Global Polymer Drug Conjugates Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Polymer Drug Conjugates Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Polymer Drug Conjugates Revenue Share by Application (2017-2022)
Table 44. Global Polymer Drug Conjugates Revenue Share by Application (2023-2028)
Table 45. Polymer Drug Conjugates Price by Application (2017-2022) & (USD/Pcs)
Table 46. Global Polymer Drug Conjugates Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 47. North America Polymer Drug Conjugates Sales by Type (2017-2022) & (K Pcs)
Table 48. North America Polymer Drug Conjugates Sales by Type (2023-2028) & (K Pcs)
Table 49. North America Polymer Drug Conjugates Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Polymer Drug Conjugates Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Polymer Drug Conjugates Sales by Application (2017-2022) & (K Pcs)
Table 52. North America Polymer Drug Conjugates Sales by Application (2023-2028) & (K Pcs)
Table 53. North America Polymer Drug Conjugates Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Polymer Drug Conjugates Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Polymer Drug Conjugates Sales by Country (2017-2022) & (K Pcs)
Table 56. North America Polymer Drug Conjugates Sales by Country (2023-2028) & (K Pcs)
Table 57. North America Polymer Drug Conjugates Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Polymer Drug Conjugates Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Polymer Drug Conjugates Sales by Type (2017-2022) & (K Pcs)
Table 60. Europe Polymer Drug Conjugates Sales by Type (2023-2028) & (K Pcs)
Table 61. Europe Polymer Drug Conjugates Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Polymer Drug Conjugates Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Polymer Drug Conjugates Sales by Application (2017-2022) & (K Pcs)
Table 64. Europe Polymer Drug Conjugates Sales by Application (2023-2028) & (K Pcs)
Table 65. Europe Polymer Drug Conjugates Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Polymer Drug Conjugates Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Polymer Drug Conjugates Sales by Country (2017-2022) & (K Pcs)
Table 68. Europe Polymer Drug Conjugates Sales by Country (2023-2028) & (K Pcs)
Table 69. Europe Polymer Drug Conjugates Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Polymer Drug Conjugates Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Polymer Drug Conjugates Sales by Type (2017-2022) & (K Pcs)
Table 72. Asia Pacific Polymer Drug Conjugates Sales by Type (2023-2028) & (K Pcs)
Table 73. Asia Pacific Polymer Drug Conjugates Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Polymer Drug Conjugates Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Polymer Drug Conjugates Sales by Application (2017-2022) & (K Pcs)
Table 76. Asia Pacific Polymer Drug Conjugates Sales by Application (2023-2028) & (K Pcs)
Table 77. Asia Pacific Polymer Drug Conjugates Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Polymer Drug Conjugates Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Polymer Drug Conjugates Sales by Region (2017-2022) & (K Pcs)
Table 80. Asia Pacific Polymer Drug Conjugates Sales by Region (2023-2028) & (K Pcs)
Table 81. Asia Pacific Polymer Drug Conjugates Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Polymer Drug Conjugates Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Polymer Drug Conjugates Sales by Type (2017-2022) & (K Pcs)
Table 84. Latin America Polymer Drug Conjugates Sales by Type (2023-2028) & (K Pcs)
Table 85. Latin America Polymer Drug Conjugates Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Polymer Drug Conjugates Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Polymer Drug Conjugates Sales by Application (2017-2022) & (K Pcs)
Table 88. Latin America Polymer Drug Conjugates Sales by Application (2023-2028) & (K Pcs)
Table 89. Latin America Polymer Drug Conjugates Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Polymer Drug Conjugates Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Polymer Drug Conjugates Sales by Country (2017-2022) & (K Pcs)
Table 92. Latin America Polymer Drug Conjugates Sales by Country (2023-2028) & (K Pcs)
Table 93. Latin America Polymer Drug Conjugates Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Polymer Drug Conjugates Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Polymer Drug Conjugates Sales by Type (2017-2022) & (K Pcs)
Table 96. Middle East and Africa Polymer Drug Conjugates Sales by Type (2023-2028) & (K Pcs)
Table 97. Middle East and Africa Polymer Drug Conjugates Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Polymer Drug Conjugates Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Polymer Drug Conjugates Sales by Application (2017-2022) & (K Pcs)
Table 100. Middle East and Africa Polymer Drug Conjugates Sales by Application (2023-2028) & (K Pcs)
Table 101. Middle East and Africa Polymer Drug Conjugates Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Polymer Drug Conjugates Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Polymer Drug Conjugates Sales by Country (2017-2022) & (K Pcs)
Table 104. Middle East and Africa Polymer Drug Conjugates Sales by Country (2023-2028) & (K Pcs)
Table 105. Middle East and Africa Polymer Drug Conjugates Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Polymer Drug Conjugates Revenue by Country (2023-2028) & (US$ Million)
Table 107. 3S Bio Corporation Information
Table 108. 3S Bio Description and Major Businesses
Table 109. 3S Bio Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. 3S Bio Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. 3S Bio Recent Developments
Table 112. Abeona Therapeutics Corporation Information
Table 113. Abeona Therapeutics Description and Major Businesses
Table 114. Abeona Therapeutics Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Abeona Therapeutics Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Abeona Therapeutics Recent Developments
Table 117. Abramson Cancer Center Corporation Information
Table 118. Abramson Cancer Center Description and Major Businesses
Table 119. Abramson Cancer Center Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Abramson Cancer Center Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Abramson Cancer Center Recent Developments
Table 122. Access Pharmaceuticals Corporation Information
Table 123. Access Pharmaceuticals Description and Major Businesses
Table 124. Access Pharmaceuticals Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. Access Pharmaceuticals Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Access Pharmaceuticals Recent Developments
Table 127. Adama Corporation Information
Table 128. Adama Description and Major Businesses
Table 129. Adama Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 130. Adama Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Adama Recent Developments
Table 132. Eyetech Corporation Information
Table 133. Eyetech Description and Major Businesses
Table 134. Eyetech Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 135. Eyetech Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Eyetech Recent Developments
Table 137. Ferring Corporation Information
Table 138. Ferring Description and Major Businesses
Table 139. Ferring Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 140. Ferring Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Ferring Recent Developments
Table 142. Flamel Technologies Corporation Information
Table 143. Flamel Technologies Description and Major Businesses
Table 144. Flamel Technologies Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 145. Flamel Technologies Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Flamel Technologies Recent Developments
Table 147. Genentech Corporation Information
Table 148. Genentech Description and Major Businesses
Table 149. Genentech Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 150. Genentech Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Genentech Recent Developments
Table 152. GlaxoSmithKline Corporation Information
Table 153. GlaxoSmithKline Description and Major Businesses
Table 154. GlaxoSmithKline Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 155. GlaxoSmithKline Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. GlaxoSmithKline Recent Developments
Table 157. Gowan Corporation Information
Table 158. Gowan Description and Major Businesses
Table 159. Gowan Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 160. Gowan Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Gowan Recent Developments
Table 162. Gynecologic Oncology Group Foundation Corporation Information
Table 163. Gynecologic Oncology Group Foundation Description and Major Businesses
Table 164. Gynecologic Oncology Group Foundation Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 165. Gynecologic Oncology Group Foundation Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Gynecologic Oncology Group Foundation Recent Developments
Table 167. JenKem Technology Corporation Information
Table 168. JenKem Technology Description and Major Businesses
Table 169. JenKem Technology Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 170. JenKem Technology Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. JenKem Technology Recent Developments
Table 172. Landec Corporation Information
Table 173. Landec Description and Major Businesses
Table 174. Landec Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 175. Landec Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Landec Recent Developments
Table 177. Lipotek Corporation Information
Table 178. Lipotek Description and Major Businesses
Table 179. Lipotek Polymer Drug Conjugates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 180. Lipotek Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Lipotek Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Polymer Drug Conjugates Distributors List
Table 185. Polymer Drug Conjugates Customers List
Table 186. Polymer Drug Conjugates Market Trends
Table 187. Polymer Drug Conjugates Market Drivers
Table 188. Polymer Drug Conjugates Market Challenges
Table 189. Polymer Drug Conjugates Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Polymer Drug Conjugates Product Picture
Figure 3. Global Polymer Drug Conjugates Market Share by Type in 2021 & 2028
Figure 3. Polymer-Dox Conjugates Product Picture
Figure 4. Polymer-Paclitaxel Conjugates Product Picture
Figure 5. Polymer-Camptothecin Conjugates Product Picture
Figure 6. Polymer-Platinate Conjugates Product Picture
Figure 7. Global Polymer Drug Conjugates Market Share by Application in 2021 & 2028
Figure 8. Cancer Treatment
Figure 9. Leukmia
Figure 10. Hepatitis
Figure 11. Others
Figure 12. Polymer Drug Conjugates Report Years Considered
Figure 13. Global Polymer Drug Conjugates Sales 2017-2028 (K Pcs)
Figure 14. Global Polymer Drug Conjugates Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Polymer Drug Conjugates Revenue 2017-2028 (US$ Million)
Figure 16. Global Polymer Drug Conjugates Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Polymer Drug Conjugates Sales Market Share by Region (2017-2022)
Figure 18. Global Polymer Drug Conjugates Sales Market Share by Region (2023-2028)
Figure 19. North America Polymer Drug Conjugates Sales YoY (2017-2028) & (K Pcs)
Figure 20. North America Polymer Drug Conjugates Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Polymer Drug Conjugates Sales YoY (2017-2028) & (K Pcs)
Figure 22. Europe Polymer Drug Conjugates Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Polymer Drug Conjugates Sales YoY (2017-2028) & (K Pcs)
Figure 24. Asia-Pacific Polymer Drug Conjugates Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Polymer Drug Conjugates Sales YoY (2017-2028) & (K Pcs)
Figure 26. Latin America Polymer Drug Conjugates Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Polymer Drug Conjugates Sales YoY (2017-2028) & (K Pcs)
Figure 28. Middle East & Africa Polymer Drug Conjugates Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Polymer Drug Conjugates Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Polymer Drug Conjugates in the World: Market Share by Polymer Drug Conjugates Revenue in 2021
Figure 31. Global Polymer Drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Polymer Drug Conjugates Sales Market Share by Type (2017-2028)
Figure 33. Global Polymer Drug Conjugates Revenue Market Share by Type (2017-2028)
Figure 34. Global Polymer Drug Conjugates Sales Market Share by Application (2017-2028)
Figure 35. Global Polymer Drug Conjugates Revenue Market Share by Application (2017-2028)
Figure 36. North America Polymer Drug Conjugates Sales Market Share by Type (2017-2028)
Figure 37. North America Polymer Drug Conjugates Revenue Market Share by Type (2017-2028)
Figure 38. North America Polymer Drug Conjugates Sales Market Share by Application (2017-2028)
Figure 39. North America Polymer Drug Conjugates Revenue Market Share by Application (2017-2028)
Figure 40. North America Polymer Drug Conjugates Sales Share by Country (2017-2028)
Figure 41. North America Polymer Drug Conjugates Revenue Share by Country (2017-2028)
Figure 42. U.S. Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Polymer Drug Conjugates Sales Market Share by Type (2017-2028)
Figure 45. Europe Polymer Drug Conjugates Revenue Market Share by Type (2017-2028)
Figure 46. Europe Polymer Drug Conjugates Sales Market Share by Application (2017-2028)
Figure 47. Europe Polymer Drug Conjugates Revenue Market Share by Application (2017-2028)
Figure 48. Europe Polymer Drug Conjugates Sales Share by Country (2017-2028)
Figure 49. Europe Polymer Drug Conjugates Revenue Share by Country (2017-2028)
Figure 50. Germany Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 51. France Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Polymer Drug Conjugates Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Polymer Drug Conjugates Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Polymer Drug Conjugates Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Polymer Drug Conjugates Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Polymer Drug Conjugates Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Polymer Drug Conjugates Revenue Share by Region (2017-2028)
Figure 61. China Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 64. India Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Polymer Drug Conjugates Sales Market Share by Type (2017-2028)
Figure 72. Latin America Polymer Drug Conjugates Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Polymer Drug Conjugates Sales Market Share by Application (2017-2028)
Figure 74. Latin America Polymer Drug Conjugates Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Polymer Drug Conjugates Sales Share by Country (2017-2028)
Figure 76. Latin America Polymer Drug Conjugates Revenue Share by Country (2017-2028)
Figure 77. Mexico Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Polymer Drug Conjugates Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Polymer Drug Conjugates Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Polymer Drug Conjugates Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Polymer Drug Conjugates Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Polymer Drug Conjugates Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Polymer Drug Conjugates Revenue Share by Country (2017-2028)
Figure 86. Turkey Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 88. U.A.E Polymer Drug Conjugates Revenue (2017-2028) & (US$ Million)
Figure 89. Polymer Drug Conjugates Value Chain
Figure 90. Polymer Drug Conjugates Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
Industry Market Size
